Home › Funds › PFM Health Sciences, LP › WAT

PFM Health Sciences, LP position in WAT

WATERS CORP · Industrials

PFM Health Sciences, LP reported holding 43,916 shares of WAT (WATERS CORP) in its Q3 2026 13F filing — a position valued at US$19.3M, representing 1.97% of its reported portfolio and ranking #16 among its reported holdings. PFM Health Sciences, LP has disclosed WAT holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)43.92K sh
Reported value held$19.30M
Portfolio Weight1.97%
First reportedQ1 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's WAT position evolved

PFM Health Sciences, LP first disclosed a stake in WAT in Q1 2024 at 38,464 shares (US$13.2M). The position peaked in Q2 2026 at 59,825 shares, worth US$22.4M. Across 11 filings, PFM Health Sciences, LP increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 43,916 shares valued at US$19.3M — a reduction of -15,909 shares quarter over quarter.. Notable position changes include a 47% trim in Q2 2024 (shares rose 24% over the following quarter), a 149% increase in Q3 2024 (shares rose 3% over the following quarter), a 50% increase in Q2 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 38.46K $13.24M New
Q2 2024 20.54K $5.96M Reduce
Q3 2024 51.06K $18.38M Add
Q4 2024 59.05K $21.91M Add
Q1 2025 51.86K $19.11M Reduce
Q2 2025 43.09K $15.04M Reduce
Q3 2025 30.75K $9.22M Reduce
Q4 2025 43.21K $16.41M Add
Q1 2026 39.76K $11.84M Reduce
Q2 2026 59.83K $22.44M Add
Q3 2026 43.92K $19.30M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WAT and 13F data

WAT (WATERS CORP) is a Industrials company. 45 other funds we track also report a position in WAT — the largest reported positions include MFS Investment Management (US$2.82B), T. Rowe Price Investment Management, Inc. (US$1.43B), Fundsmith LLP (US$995.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WAT

All WAT fund holders →

FAQ

How long has PFM Health Sciences, LP held WAT?

PFM Health Sciences, LP has disclosed WAT holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is PFM Health Sciences, LP's current position in WAT?

As of Q3 2026, PFM Health Sciences, LP holds 43.92K shares of WAT (WATERS CORP), valued at $19.30M, representing 1.97% of its reported portfolio and ranking #16.

Has PFM Health Sciences, LP been buying or selling WAT?

In the latest 13F filing (Q3 2026), PFM Health Sciences, LP reduced its position in WAT. The position peaked in Q2 2026 at 59.83K shares.

Which other funds hold WAT?

Other major institutional holders of WAT include MFS Investment Management, T. Rowe Price Investment Management, Inc., Fundsmith LLP, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.